Personalized medicine: Challenge and promise

Journal of Cancer Education

Volumn 27, Issue SUPPL. 1, 2012, Pages

  Kaur, Judith Salmon ^a   Petereit, Daniel G ^b,c  

^a MAYO CLINIC CANCER CENTER   (United States)

^b RAPID CITY REGIONAL HOSPITAL   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

American indian; Cancer health disparities; CBPR; Genotype

Indexed keywords

AMERICAN INDIAN; ARTICLE; ESKIMO; ETHNOLOGY; GENETICS; HEALTH DISPARITY; HUMAN; NEOPLASM; PARTICIPATORY RESEARCH; PERSONALIZED MEDICINE; PSYCHOLOGICAL ASPECT; STATISTICS; UNITED STATES;

COMMUNITY-BASED PARTICIPATORY RESEARCH; HEALTH STATUS DISPARITIES; HUMANS; INDIANS, NORTH AMERICAN; INDIVIDUALIZED MEDICINE; INUITS; NEOPLASMS; UNITED STATES;

EID: 84863721250     PISSN: 08858195     EISSN: 15430154     Source Type: Journal    
DOI: 10.1007/s13187-012-0322-7     Document Type: Conference Paper

References (23)

1. Hirschfield GM, Amos CI, Siminovitch KA (2010) Navigating the road to personalized medicine: can we believe? CMAJ 182 (7):651-652.
2. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(1):1200-1205.
3. Roberts R (2008) Personalized medicine: a reality whting this decade. J Cardiovasc Transl Res 1(1):11-16.
4. McGuire AL, Cho MK, McGuire SE (2007) Medicine: the future of personal genomics. Science 317:1687.
5. Potti A, Schilsky RL, Nevins JR (2010) Refocusing the war on cancer: the critical role of personalized treatment. Sci Transl Med 2 (28):28cm13.
6. Petereit DG, Rogers D, Govern F, Coleman N, Osburn CH, Howard SP, Kaur J, Burhansstipanov L, Fowler CJF, Chappell R, Mehta MP (2004) Increasing access to clinical cancer trials and emerging technologies for minority populations: The Native American Project. Journal of Clinical Oncology 22(22):4452- 4455.
7. Petereit DG, Burhansstipanov L (2008) Establishing trusting partnerships for successful recruitment of American Indians to clinical trials. Cancer Control 15(3):260-268.
8. Petereit DG, Molloy K, Reiner ML, Helbig P, Cina K, Miner R, Spotted Tail C, Rost C, Conroy P, Roberts CR (2008) Establishing a patient navigator program to reduce cancer disparities in the American Indian communities of Western South Dakota: initial observations and results. Cancer Control 15(3):254-259.
9. Guadagnolo BA, Boylan A, Sargent M, Koop D, Brunette D, Kanekar S, Short Bull V, Molloy K, Petereit DG (2011) Patient navigation for American Indians undergoing cancer treatment: utilization and impact on care delivery in a regional health care center. Cancer 117(12):2754-2761.
10. Guadagnolo BA, Cina K, Helbig P, Molloy K, Reiner M, Cook EF, Petereit DG (2009) Medical mistrust and less satisfaction with health care among Native Americans presenting for cancer treatment. J Health Care Poor Underserved 20(1):210-226.
11. Kanekar S, Petereit DG (2009) Walking forward: a program designed to lower cancer mortality rates among American Indians in western South Dakota. S D Med 62(4):151-157.
12. Guadagnolo BA, Cina K, Helbig P, Molloy K, Reiner M, Cook EF, Petereit DG (2009) Assessing cancer stage and screening disparities among Native American cancer patients. When free primary care is not enough. Public Health Rep 124:79-89.
13. Sparks SMA, Koscik R, Kanekar S, et al. (2010) Self-reported barriers to accessing health care among Native Americans in South Dakota. Journal of Healthcare to the Poor and the Underserved.
14. Guadagnolo BA, Cina K, Helbig P, et al. (2009) Assessing cancer stage and screening disparities among Native American cancer patients: when free primary care is not enough. Public Health Rep 124:79-89.
15. Guadagnolo B, Petereit D, Helbig P, Koop D, Kussman P, Fox E, Patnaik A (2009) Involving American Indians and medically underserved populations in cancer clinical trials. Clin Trials 6 (6):610-617.
16. Petereit DG, Rogers D, Helbig P, et. al. (2004) Geographic distance from the cancer center may be a treatment barrier for American Indians undergoing radiotherapy. In: Intercultural Cancer Council 9th Biennial Symposium on Minorities, the Medically Underserved, and Cancer. Washington, DC.
17. Ritter MA, Forman JD, Kupelian P, Petereit DG, Lawton CA, Chappell RJ, Tomé WA (2009) A phase I/II trial of increasingly hypofractionated radiation therapy for prostate cancer. American Society of Therapeutic Radiation Oncology 2009 Annual Meeting.
18. Swartz MJ, Petereit DG (2010) The role of radiation therapy in the management of lung, prostate and colorectal cancer in South Dakota Medicine. S D Med 2010:60-66, Special issue.
19. Petereit DG, Sarkaria JN, Hartmann TJ, Kinsella TJ, Chappell R, Thomadsen BR, Stitt JA, Buchler DA (1995) The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 32:1301-1307.
20. Petereit DG, Moser A, Hahn J, Boyland A, Kanekar S, Ritter M, Bentzen SM, Koop D, Kaur J, Mehta M(2010) Ataxia telangiectasia mutated (ATM) gene variants in American Indians. Int J Radiat Oncol Biol Phys 78(3):S90.
21. Harmon A (2010) Indian tribe wins fight to limit research of its DNA. In: New York Times. New York, 2010, April 21.
22. Hart S, Sobraske K (2003) Investigative report concerning the medical genetics project at Havasupai, 23 December 2003; available at the Arizona State University Law Library and www.geneticpiracy.com/Documents/HartReport.pdf.
23. Burke TW, Hoskins WJ, Heller PB, Bibro MC, Weiser EB, Park RC (1987) Prognostic factors associated with radical hysterectomy failure. Gynecol Oncol 26:153-159.